From Wikipedia, the free encyclopedia
Dichloralphenazone
Combination of
Phenazone Analgesic
Chloral hydrate Sedative
Clinical data
MedlinePlus a601064
Routes of
administration
Oral
ATC code
Legal status
Legal status
Identifiers
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
CompTox Dashboard ( EPA)
ECHA InfoCard 100.006.861 Edit this at Wikidata
 ☒NcheckY  (what is this?)   (verify)

Dichloralphenazone is a 1:2 mixture of antipyrine with chloral hydrate. In combination with paracetamol and isometheptene, it is the active ingredient of medications for migraine and tension headaches, including Epidrin and Midrin. Performance impairments are common with this drug and caution is advised, for example when driving motor vehicles. Additional uses of dichloralphenazone include sedation for the treatment of short-term insomnia, although there are probably better drug choices for the treatment of insomnia. [1]

See also

References

  1. ^ Hindmarch I, Parrott AC (1980). "The effects of combined sedative and anxiolytic preparations on subjective aspects of sleep and objective measures of arousal and performance the morning following nocturnal medication. I: Acute doses". Arzneimittel-Forschung. 30 (6): 1025–8. PMID  6106498.

External links

From Wikipedia, the free encyclopedia
Dichloralphenazone
Combination of
Phenazone Analgesic
Chloral hydrate Sedative
Clinical data
MedlinePlus a601064
Routes of
administration
Oral
ATC code
Legal status
Legal status
Identifiers
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
CompTox Dashboard ( EPA)
ECHA InfoCard 100.006.861 Edit this at Wikidata
 ☒NcheckY  (what is this?)   (verify)

Dichloralphenazone is a 1:2 mixture of antipyrine with chloral hydrate. In combination with paracetamol and isometheptene, it is the active ingredient of medications for migraine and tension headaches, including Epidrin and Midrin. Performance impairments are common with this drug and caution is advised, for example when driving motor vehicles. Additional uses of dichloralphenazone include sedation for the treatment of short-term insomnia, although there are probably better drug choices for the treatment of insomnia. [1]

See also

References

  1. ^ Hindmarch I, Parrott AC (1980). "The effects of combined sedative and anxiolytic preparations on subjective aspects of sleep and objective measures of arousal and performance the morning following nocturnal medication. I: Acute doses". Arzneimittel-Forschung. 30 (6): 1025–8. PMID  6106498.

External links


Videos

Youtube | Vimeo | Bing

Websites

Google | Yahoo | Bing

Encyclopedia

Google | Yahoo | Bing

Facebook